CANCER CENTER AND RESEARCH INSTITUTE

螺杆Lee Moffitt癌症中心和研究所于1986年开业， 南佛罗里达大学校园的使命是“为 癌症的预防和治疗。“癌症中心与 多层次的大学结构，并受益于明确的 中心主任和中心主任的明确权力 独立的财务状况。在过去的五年里，癌症中心 已投资超过1800万美元用于研究项目，人员和 基础设施演进此外，耗资1400万美元的研究中心翻新工程 中心和其他实验室在同一时期扩大 研究空间从1993年的18，000平方英尺增加到目前的90，000平方英尺。的 对研究的承诺补充了强大的临床操作， 医院，每年收治4,000名住院病人;诊所， 1995-96年，超过80，000名患者就诊;以及独特的终身癌症 筛查中心，它看到7,000多个健康和高风险 个人每年。 癌症中心的四个已建立的研究项目包括分子 肿瘤学、免疫学、临床研究和癌症控制。的 课程建立在来自多个国家的教师的集体优势之上。 各院系和优秀的临床护理实力雄厚 设置. 癌症中心支持补助金将使癌症中心能够扩大 其研究重点包括遗传学，将作为一个联合基础 科学和癌症控制的努力。此外，CCSG将支持 扩展共享资源，以适应增长带来的使用量增加 在人员和研究范围上。共享资源包括Flow 细胞计数，病理学，分子生物学，玻璃清洗，分子成像， 生物统计学、数据管理和癌症研究中的动物核心 该中心将在明年增加转基因服务。最 重要的是，CCSG将提供重点支持， 通过高级领导人的支持发展转化研究 和项目负责人在与癌症中心成员合作时的角色 促进实验室-临床-实验室的互动和翻译。

The H. Lee Moffitt Cancer Center & Research Institute opened in 1986 on the University of South Florida campus with the mission "to contribute to the prevention and cure of cancer." The Cancer Center enjoys close ties at multiple levels of the University structure, and benefits from the clearly articulated authorities of the Center Director and the Center's independent financial status. Over the past five years, the Cancer Center has invested over $18 million in research programs, personnel and infrastructure. In addition, a $14 million renovation of the Research Center and other laboratories during the same time period expanded research space from 18,000 sf in 1993 to 90,000 sf currently. The commitment to research complements the strong clinical operation of the hospital, which admits 4,000 inpatients per year; the clinics, which has more than 80,000 patient visits in 1995-96; and the unique Lifetime Cancer Screening Center, which sees more than 7,000 healthy and high risk individuals each year. The Cancer Center's four established research program include Molecular Oncology, Immunology, Clinical Investigations and Cancer Control. The programs have built on the collective strengths of faculty from multiple departments and colleges and the excellence of a strong clinical care setting. The Cancer Center Support Grant will enable the Cancer Center to expand its research focus to include genetics, to be developed as a joint basic science and cancer control effort. Additionally, the CCSG will support expansion of shared resources to accommodate increased usage from growth in personnel and scope of research. Shared resources includes Flow Cytometry, Pathology, Molecular Biology, Glass Wash, Molecular Imaging, Biostatistics, Data Management, and an animal core in the Cancer Research Center which will add transgenic services in the coming year. Most importantly, the CCSG will provide focused support for enhanced development of translational research through support of senior leaders and program leaders in their roles as they work with cancer center members to promote laboratory-clinical-laboratory interactions and translations.